Stevo Julius Selected Research

Creatinine

7/2014	Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.
4/2012	Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study.
3/2008	Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
7/2007	Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
11/2006	Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
9/2004	Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
4/2003	Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?
11/2002	Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stevo Julius Research Topics

Disease

63	Hypertension (High Blood Pressure) 03/2022 - 03/2002
32	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2020 - 03/2002
21	Stroke (Strokes) 01/2020 - 03/2002
18	Myocardial Infarction 01/2020 - 03/2002
9	Heart Failure 01/2020 - 06/2004
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 03/2002
7	Diabetes Mellitus 01/2016 - 09/2002
6	Atrial Fibrillation 10/2020 - 03/2005
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2006
4	Isolated Systolic Hypertension 01/2018 - 09/2002
4	Essential Hypertension 12/2013 - 08/2003
4	Prehypertension 10/2008 - 04/2006
3	Obesity 02/2014 - 10/2004
3	Insulin Resistance 02/2014 - 01/2005
3	Albuminuria 03/2008 - 09/2004
3	Coronary Disease (Coronary Heart Disease) 11/2006 - 06/2004
2	Proteinuria 01/2016 - 11/2006
2	Myocardial Ischemia (Ischemic Heart Diseases) 07/2014 - 04/2012
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 07/2014 - 04/2012
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2012 - 03/2005
2	Overweight 11/2009 - 07/2005
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2007 - 01/2005
2	Hypertrophy 04/2005 - 03/2005
1	Inflammation (Inflammations) 02/2014
1	Neoplasms (Cancer) 09/2010
1	Weight Gain 11/2009
1	White Coat Hypertension 06/2009
1	Tachycardia (Tachyarrhythmias) 05/2007
1	Transient Ischemic Attack 11/2006
1	Peripheral Arterial Disease 11/2006
1	Carotid Stenosis (Carotid Artery Stenosis) 03/2006
1	Embolic Stroke 03/2005
1	Cardiomegaly (Heart Hypertrophy) 01/2005
1	Orthostatic Hypotension (Postural Hypotension) 01/2004
1	Vascular Diseases (Vascular Disease) 08/2003
1	Heart Diseases (Heart Disease) 04/2003
1	Hemorrhage 11/2002

Drug/Important Bio-Agent (IBA)

35	Losartan (Cozaar)FDA LinkGeneric 03/2022 - 03/2002
33	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 03/2002
30	Atenolol (Tenormin)FDA LinkGeneric 07/2014 - 03/2002
14	Valsartan (Vals)FDA Link 01/2021 - 06/2004
12	Angiotensin Receptor AntagonistsIBA 11/2014 - 11/2004
9	candesartanIBA 01/2020 - 07/2002
8	Amlodipine (Norvasc)FDA LinkGeneric 01/2020 - 06/2004
8	CreatinineIBA 07/2014 - 11/2002
5	HDL CholesterolIBA 10/2020 - 01/2005
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2014 - 01/2006
5	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2010 - 03/2005
4	Perindopril FDA LinkGeneric 01/2020 - 01/2004
4	CholesterolIBA 01/2016 - 04/2003
4	Glucose (Dextrose)FDA LinkGeneric 07/2014 - 01/2005
4	AlbuminsIBA 07/2014 - 09/2004
4	Pharmaceutical PreparationsIBA 10/2008 - 09/2002
3	Triglycerides (Triacylglycerol)IBA 02/2014 - 01/2005
2	Nifedipine (Adalat)FDA LinkGeneric 12/2013 - 10/2008
2	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2009 - 10/2004
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2009 - 05/2007
2	A 19IBA 12/2008 - 09/2007
2	DiureticsIBA 05/2008 - 03/2002
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2007 - 10/2004
2	LDL CholesterolIBA 10/2006 - 07/2005
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2006 - 11/2004
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2005 - 11/2002
2	Insulin (Novolin)FDA Link 07/2005 - 01/2005
2	Angiotensin IIIBA 01/2005 - 08/2003
1	paragonIBA 01/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020
1	Irbesartan FDA LinkGeneric 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2020
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2020
1	Drug CombinationsIBA 02/2015
1	A 159IBA 03/2012
1	Hormones (Hormone)IBA 11/2009
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 08/2007
1	Angiotensin II Type 1 Receptor BlockersIBA 07/2006
1	Valsartan Drug Combination Amlodipine FDA Link 07/2006
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2006
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 01/2006
1	candesartan cilexetil (Amias)FDA Link 07/2005
1	ReninIBA 01/2005
1	AngiotensinsIBA 01/2005
1	AldosteroneIBA 01/2005
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 10/2004
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 08/2003
1	Indicators and Reagents (Reagents)IBA 03/2002

Therapy/Procedure

26	Therapeutics 01/2020 - 08/2003
3	Drug Therapy (Chemotherapy) 01/2020 - 08/2008
1	Ambulatory Care (Outpatient Care) 01/2008